Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.

MLA

Toyoda, Hidenori, et al. “Improved Survival of Viral Hepatocellular Carcinoma but Not Non‐viral Hepatocellular Carcinoma from 2000 to 2020: A Multi‐centre Cohort Study of 6007 Patients from High‐volume Academic Centres in Japan.” Alimentary Pharmacology & Therapeutics, vol. 56, no. 4, Aug. 2022, pp. 694–701. EBSCOhost, https://doi.org/10.1111/apt.17088.

APA

Toyoda, H., Kariyama, K., Hiraoka, A., Tsuji, K., Ishikawa, T., Hatanaka, T., Naganuma, A., Yasuda, S., Nouso, K., Kakizaki, S., Kumada, T., Innes, H., & Johnson, P. J. (2022). Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan. Alimentary Pharmacology & Therapeutics, 56(4), 694–701. https://doi.org/10.1111/apt.17088

Chicago

Toyoda, Hidenori, Kazuya Kariyama, Atsushi Hiraoka, Kunihiko Tsuji, Toru Ishikawa, Takeshi Hatanaka, Atsushi Naganuma, et al. 2022. “Improved Survival of Viral Hepatocellular Carcinoma but Not Non‐viral Hepatocellular Carcinoma from 2000 to 2020: A Multi‐centre Cohort Study of 6007 Patients from High‐volume Academic Centres in Japan.” Alimentary Pharmacology & Therapeutics 56 (4): 694–701. doi:10.1111/apt.17088.